AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
FibroBiologics, Inc. has paid off all outstanding amounts under convertible promissory notes issued to YA II PN, Ltd. This marks the end of the first tranche of a $25 million standby equity purchase agreement between the two parties. The agreement allows FibroBiologics to sell up to $25 million of its common stock to YA II PN, Ltd. over the course of two years.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet